AcelRx Pharmaceuticals (ACRX)

Add to Watchlists Create an Alert
7.29 +0.89  +13.91%   NASDAQ May 22, 4:59PM BATS Real time Currency in USD

AcelRx Pharmaceuticals Cash from Financing Quarterly:

42.33M for Dec. 31, 2012
View Full Chart

AcelRx Pharmaceuticals Cash from Financing Quarterly Chart

    AcelRx Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 42.33M
    Sept. 30, 2012 -1.746M
    June 30, 2012 9.091M
    March 31, 2012 0.089M
    Dec. 31, 2011 9.998M
    Sept. 30, 2011 0.146M
    June 30, 2011 5.498M
       
    March 31, 2011 33.96M
    Dec. 31, 2010 -1.22M
    Sept. 30, 2010 6.815M
    June 30, 2010 -1.162M
    March 31, 2010 -1.068M
    Sept. 30, 2009 -1.627M

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    ACRX Cash from Financing Quarterly Benchmarks

    Companies
    Astex Pharmaceuticals
    Cyanotech Corporation -0.019M
    Intercept Pharmaceuticals

    ACRX Cash from Financing Quarterly Rankings

    Overall 93rd percentile
    502 of 8005
    Sector 94th percentile
    40 of 686 in Healthcare
    Industry 94th percentile
    3 of 55 in Drug Manufacturers - Major

    ACRX Cash from Financing Quarterly Range, Past 5 Years

    Minimum -1.746M Sep 2012
    Maximum 42.33M Dec 2012
    Average 7.778M